Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Ovarian Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
46 drugs · 161 active trials
11 drugs · 195 active trials
5 drugs · 126 active trials
Data updated 19 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Toremifene | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 22, 1999 |
| Triciribine | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2014-09 |
| Elimusertib | Phase 1 | Phase 1 | 2 | 0 | 0 | 3 | 0 | — | — | Feb 26, 2020 |
| Mitomycin | Phase 1 | Phase 1 | 2 | 2 | 0 | 2 | 0 | — | — | Aug 21, 2020 |
| Lunresertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Mar 20, 2024 |
| Vistusertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Nov 11, 2014 |
| Buparlisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2008-11 |
| Busulfan | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 1998-11 |
| Sonidegib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2013-09 |
| Abexinostat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Mar 31, 2021 |
| Abiraterone | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Feb 10, 2021 |
| Agerafenib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 14, 2018 |
| Alectinib | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jan 30, 2023 |
| Alvespimycin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-07 |
| Azacitidine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-02 |
| Bosutinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 10, 2019 |
| Brentuximab Vedotin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 29, 2020 |
| Denosumab | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Mar 14, 2019 |
| Margetuximab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 18, 2017 |
| O6-Benzylguanine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2000-06 |
| Onalespib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 19, 2017 |
| Perifosine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-02 |
| Picoplatin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-04 |
| Pilaralisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-09 |
| Plerixafor | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2015-06 |
| Retifanlimab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Feb 3, 2021 |
| Ridaforolimus | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jun 13, 2011 |
| Valproic Acid | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2015-08 |
| Vatalanib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2005-09 |
| Vemurafenib | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jan 30, 2023 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.